TAR-210 results show 90 percent recurrence-free survival
Updated results reinforce the potential of TAR-210 to transform treatment of non-muscle-invasive bladder cancer with fibroblast growth factor receptor...
Source: globenewswire.com
Gene Alterations News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gene Alterations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gene Alterations Today - Breaking & Trending Today
First Results with Erdafitinib-Releasing Intravesical
Investigational TAR-210 first-in-human results highlight the potential for local sustained release of erdafitinib with a novel intravesical delivery...
Source: globenewswire.com
Results from Phase 2 THOR-2 Study Showed Improved Rates of
Data from Cohort 1 of the Phase 2 THOR-2 study showed oral erdafitinib reduced the risk of disease recurrence or death compared with intravesical...
Source: globenewswire.com
Janssen Submits Marketing Authorisation Application to the
Pending approval, erdafitinib, an investigational, once-daily oral pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor,1 will become the...
Source: globenewswire.com
Genetic Alterations Discovered in Hispanic Men With Prostate Cancer
In an exploratory analysis, Hispanic men with primary and metastatic prostate cancer exhibited higher frequencies of certain altered genes compared to non-Hispanic men.
Source: ajmc.com